NCT00531583已完成不适用
Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 350
- 试验地点
- 2
- 主要终点
- Efficacy
研究概览
简要总结
Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st & 2nd complete remission w/no HLA matched related donor
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with AML in 1st & 2nd complete remission w/no HLA matched related donor
排除标准
- 未提供
结局指标
主要结局
Efficacy
时间窗: 2009-2015
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
已完成
不适用
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1JPRN-UMIN000012546ishiwaki Municipal Hospital18
招募中
不适用
Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma.multiple myelomaJPRN-UMIN000038905Tokyo-Kita Medical Center20
已完成
2 期
Autologous peripheral blood stem cell transplantation using MEAM regimen with HAART for refractory and relapsed HIV associated lymphoma: multicentered phase2 clinical trialRefractory and relapsed HIV associated lymphomaJPRN-UMIN000003159Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group18
已完成
2 期
Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaMultiple MyelomaPlasma Cell NeoplasmNCT00028600Alliance for Clinical Trials in Oncology60